Clinical Trials on Aggressive Non-Hodgkin Lymphoma
Total 5330 results
-
Institute of Hematology & Blood Diseases Hospital...CSPC Ouyi Pharmaceutical Co., Ltd.Active, not recruiting
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
National Cancer Institute (NCI)CompletedNon-Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSezary Syndrome | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Folliculotropic Mycosis Fungoides | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Cutaneous...United States
-
Hoffmann-La RocheAbbVieCompletedFollicular LymphomaUnited States, Italy, Canada, Australia, Belgium, United Kingdom, Germany, France
-
Ascenta TherapeuticsCompletedFollicular LymphomaUnited States
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
NCIC Clinical Trials GroupCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaMacedonia, The Former Yugoslav Republic of
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaSpain, France, United Kingdom, Germany, Australia, Italy
-
Hoffmann-La RocheCompletedA Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
BiogenTerminatedLymphoma, Non-Hodgkin's
-
BiogenTerminated
-
French Innovative Leukemia OrganisationUnknown
-
French Innovative Leukemia OrganisationUnknown
-
BiogenTerminatedLymphoma, Non-Hodgkin'sUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Sana BiotechnologyRecruitingNon Hodgkin's Lymphoma | Large B-cell LymphomaUnited States
-
Clinica Universidad de Navarra, Universidad de...Spanish National Health SystemUnknownFollicular Lymphoma | Follicular Non-Hodgkin´s Lymphoma | Autologous Effector LymphocytesSpain
-
Amgen Research (Munich) GmbHCompletedNon-Hodgkin's Lymphoma, RelapsedGermany
-
Nanjing Yoko Biomedical Co., Ltd.CompletedB-Cell LymphomaChina
-
Mayo ClinicRecruitingIndolent B-Cell Non-Hodgkin Lymphoma | Recurrent Indolent Non-Hodgkin Lymphoma | Refractory Indolent Non-Hodgkin Lymphoma | Recurrent Indolent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Washington University School of MedicineGenentech, Inc.RecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed B-Cell Lymphoma | Follicular Lymphoma Grade 3BUnited States
-
Lymphoma Study AssociationCompleted
-
Mirati Therapeutics Inc.TerminatedHodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)United States
-
920th Hospital of Joint Logistics Support Force...Shanghai PerHum Therapeutics Co., Ltd.Recruiting
-
Margrethe Langer BroUniversity of Aarhus; Danish Cancer SocietyCompletedNon Hodgkin´s Lymphomas | Hodgkin´s LymphomasDenmark
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.RecruitingAcute Lymphoblastic Leukemia | Non Hodgkin LymphomaChina
-
Gilead SciencesCompletedFollicular Non-Hodgkin's Lymphoma RefractorySpain, France, Ireland, Italy, Greece, Germany, United Kingdom, Sweden, Belgium, Portugal
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent and Refractory B-cell Non-Hodgkin's LymphomaChina
-
Eucure (Beijing) Biopharma Co., LtdRecruitingAdvanced Solid Tumors | Relapsed Or Refractory Non-Hodgkin LymphomaChina
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom, France
-
Adam KittaiRecruitingRecurrent Transformed Non-Hodgkin Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Recurrent Transformed... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Transformed Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsXOMA (US) LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States, Belgium, Canada, Italy, France, Hong Kong, Australia, United Kingdom, Singapore, Korea, Republic of, Germany
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingB-cell Non-Hodgkin's LymphomaChina
-
Shanghai Henlius BiotechCompleted
-
Shanghai Henlius BiotechCompleted
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Withdrawn
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
University of WashingtonRecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin LymphomaUnited States
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHigh Risk Non-Hodgkin's LymphomaUnited States